Leveraging Liquid Biopsies in Clinical Development Across a Portfolio

Time: 2:15 pm
day: Day One

Details:

• Finding the specific driver of disease to inform target identification

• Overcoming key challenges in translation to clinical trials

• Exploring sensitivity levels required for biomarker and analyte types across a portfolio

Speakers: